Twelve-Month Real-World Use of an Advanced Hybrid Closed-Loop System Versus Previous Therapy in a Dutch Center For Specialized Type 1 Diabetes Care
Use of MM780G system results in significant and sustained glycemic improvements, consistent across age groups and irrespective of previous treatment modalities.
Authors
- Henk J. Veeze (ORCID: https://orcid.org/0000-0003-0250-9380)
- Dick Mul (ORCID: https://orcid.org/0000-0001-8095-9155)
- Ohad Cohen (ORCID: https://orcid.org/0000-0003-4337-1795)
- Javier Castañeda (ORCID: https://orcid.org/0000-0003-0752-8847)
- Arcelia Arrieta (ORCID: https://orcid.org/0009-0003-1684-0258)
- Tim R. A. van den Heuvel (ORCID: https://orcid.org/0000-0002-3907-6876)
- Pim Dekker (ORCID: https://orcid.org/0000-0002-1405-8460)
- Henk‐Jan Aanstoot (ORCID: https://orcid.org/0000-0002-5534-1633)
Institutions
- Medtronic (Netherlands) (NL)
- Medtronic (Switzerland) (CH)
Publication Details
- Journal
- Journal of Diabetes Science and Technology
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1177/19322968241290259
- Citations
- 8
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 2.86